8-K
false 0001814287 0001814287 2023-08-25 2023-08-25 0001814287 abl:CommonStockParValue0.0001PerShareMember 2023-08-25 2023-08-25 0001814287 abl:WarrantsEachWholeWarrantExercisableForOneShareOfCommonStockAtAnExercisePriceOf11.50PerShareMember 2023-08-25 2023-08-25

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or Section 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): August 25, 2023

 

 

Abacus Life, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39403   85-1210472
(State or other jurisdiction
of incorporation or organization)
  (Commission
File Number)
  (I.R.S. Employer
Identification Number)

2101 Park Center Drive, Suite 170

Orlando, Florida 32835

(800) 561-4148

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

 

 

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation to the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbols

 

Name of each exchange
on which registered

Common stock, par value $0.0001 per share   ABL   The NASDAQ Stock Market LLC
Warrants, each whole warrant exercisable for one share of common stock at an exercise price of $11.50 per share   ABLLW   The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 


Item 2.02. Results of Operations and Financial Condition

On August 25, 2023, Abacus Life, Inc. released the historical second quarter 2022 financials for Abacus Settlements, LLC and Longevity Market Assets, LLC (the predecessor companies which merged with and into the Company effective as of June 30, 2023 and which currently comprise all of the business of the Company). The full text of this release is included here as Exhibit 99.1 hereto.

Item 9.01. Financial Statement and Exhibits.

 

(a)

Exhibits.

 

99.1    Historical Financial Release dated August 25, 2023
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

*

Exhibit 99.1 is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section, nor shall Exhibit 99.1 be deemed incorporated by reference into any filing of the Company under the Securities Act, in each case, whether made before or after the date hereof, regardless of any general incorporation language in such filing, except as expressly set forth in such filing.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    Abacus Life, Inc.
Date: August 25, 2023     By:  

/s/ Jay Jackson

    Name:   Jay Jackson
    Title:   Chief Executive Officer

 

2

EX-99.1

Exhibit 99.1

ABACUS LIFE PRESENTS HISTORICAL QUARTERLY AND FULL YEAR 2022 FINANCIALS

ORLANDO, Fla. – August 25, 2023 – Abacus Life, Inc. (“Abacus” or the “Company”) (NASDAQ: ABL), a leading buyer of life insurance policies and vertically integrated alternative asset manager specializing in specialty insurance products, today is releasing its unaudited historical quarterly and full year 2022 financials for Abacus Settlements, LLC (“AS”) and Longevity Market Assets, LLC (“LMA” and, together with AS, the “Predecessor Companies”). The Predecessor Companies are the predecessor companies which merged with and into the Company effective as of June 30, 2023 and which currently comprise all of the business of the Company. In addition, for illustrative purposes only, the Company is providing historical quarterly and full year 2022 financials of the Predecessor Companies on a pro forma combined basis (the “Pro Forma Financials”).

The Company is also providing financial information from last year to permit investors and analysts to understand more about the financial results for the business from 2022 for comparison purposes. The financial information related to Abacus Settlements, LLC and Longevity Market Assets, LLC is being presented for informational purposes only and should not be deemed to imply future performance of the Company. Anyone interested in the Company’s current year financial information should consult its Quarterly Report on Form 10-Q.

Safe Harbor Statement

Statements made in this press release that are not historical facts, including statements accompanied by words such as “will,” “believe,” “estimate,” “expect,” “intend,” “anticipate,” “goals,” “prospects,” or similar words, are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the Company’s plans and performance. These statements are based on management’s estimates, assumptions and projections as of the date of this release and are not guarantees of future performance. Actual results may differ materially from the results expressed or implied in these statements as the result of risks, uncertainties and other factors including, but not limited to: the fact that our loss reserves are bases on estimates and may be inadequate to cover our actual losses; the failure to properly price our insurance policies; the geographic concentration of our business; the cyclical nature of our industry; the impact of regulation on our business; the effects of competition; failing to sustain our relationships with independent agencies; the failure to meet our investment objectives; the inability to acquire additional capital on favorable terms; the effects of acts of terrorism and the factors set forth in the Company’s filings with the Securities and Exchange Commission (the “SEC”), including the Annual Report on Form 10-K and Quarterly Report on Form 10-Q and subsequent periodic reports. The Company cautions you not to place undue reliance on the forward-looking statements contained in this release. Any forward–looking statements speak only as of their dates. The Company does not undertake any obligation to publicly update or revise any forward-looking statements to reflect future events, information or circumstances that arise after the date of this release.

Non-GAAP Financial Measures

This press release includes references to Adjusted EBITDA, a non-GAAP financial measure. Non-GAAP financial measures are financial measures that are derived from the consolidated financial statements, but that are not presented in accordance with generally accepted accounting principles in the United States (GAAP). The Company uses this non-GAAP financial measure and other key metrics internally to facilitate analysis of financial and business trends and for internal planning and forecasting purposes. The Company believes this non-GAAP financial measure, when taken collectively, may be helpful to investors because it provides consistency and comparability with past financial performance by excluding certain items that may not be indicative of the business, results of operations, or outlook. However, this non- GAAP financial measure has limitations as an analytical tool and is presented for supplemental informational purposes only. It should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with GAAP. In particular, other companies, including companies in the Company’s industry, may report Adjusted EBITDA or similarly titled measures but calculate them differently, which reduces its usefulness as comparative measures.

Reconciliation of GAAP Measures to Non-GAAP Measures

Set forth below Net Income in each of the following tables is a reconciliation of Adjusted EBITDA to GAAP Net Income, the most directly comparable GAAP measure, for each of the periods presented.

Basis of Pro Forma Presentation

The Pro Forma Financials have been adjusted to give pro forma effect to the combination of the Predecessor Companies with the Company. The adjustments in the Pro Forma Financials have been identified and presented to provide relevant information necessary for an accurate understanding of the Company following the mergers with the Predecessor Companies.

The Pro Forma Financials are provided for illustrative purposes only. The financial results may have been different had the Company and the Predecessor Companies always been combined. You should not rely on the Pro Forma Financials as being indicative of the historical results that would have been achieved had the Company and the Predecessor Companies always been combined or the future results that the Company will experience.

About Abacus

Abacus is a leading vertically integrated alternative asset manager specializing in life insurance products. Since 2004, the Company has purchased life insurance policies from consumers seeking liquidity and has actively managed those policies over time (via trading, holding, and/or servicing). With over $2.9 billion in face value of policies purchased, Abacus has helped thousands of clients maximize the value of their life insurance.

Over the past 19 years, the Company has built an institutionalized origination and portfolio management process that is supported by an 84-person team, long-term relationships with 78 institutional partners and 30,000 financial advisors, and the ability to operate in 49 states. The Company has serviced approximately $950 million in policies and has managed assets for large asset managers and third-party investment funds.


Abacus’ leadership team averages 20+ years of experience and consists of innovators since the life settlements industry’s inception in the mid-90s.

The Company is a proud member of the Life Insurance Settlements Association (LISA) and complies with HIPAA and privacy laws to maintain and protect confidentiality of financial, health, and medical information. Abacus is also proud to be a BBB Accredited Business with an A+ rating.

www.Abacuslife.com

Contact:

Abacus Life Investor Relations

investors@abacuslife.com

Abacus Life Public Relations

press@abacuslife.com


LONGEVITY MARKET ASSETS, LLC AND ABACUS SETTLEMENTS, LLC COMBINED  
PROFORMA STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME  
FY 2022  
     Three months
ended
March 31,
     Three months
ended
June 30,
    Three months
ended
September 30,
     Three months
ended
December 31,
     Full Year  
     2022 Q1      2022 Q2     2022 Q3      2022 Q4      2022  

Revenues

             

Origination Revenue

     7,322,747        5,691,916       6,031,481        6,157,319        25,203,463  

Portfolio servicing revenue

     570,905        419,422       382,245        98,400        1,470,972  

Active management revenue

             

Investment Income from life insurance policies held using investment method

     8,015,000        5,965,466       10,629,978        13,218,386        37,828,829  

Change in fair value of life insurance policies (policies held using fair value method)

     1,291,492        (1,291,492     3,801,031        1,612,721        5,413,751  

Total active management revenue

     9,306,492        4,673,974       14,431,008        14,831,106        43,242,581  

Total revenues

     17,200,144        10,785,312       20,844,734        21,086,826        69,917,016  


Cost of revenues (excluding depreciation stated below)

     6,635,650       4,238,051       5,618,972       6,313,464       22,806,136  

Gross profit

     10,564,495       6,547,262       15,225,762       14,773,362       47,110,880  

Operating expenses:

          

Sales and marketing

     630,000       1,019,498       14,905       931,737       2,596,140  

General, administrative and other

     2,381,512       2,213,550       2,343,877       2,801,889       9,740,828  

Other operating expense

     —         —         (2,141     —         (2,141

Depreciation

     3,983       4,146       6,373       4,087       18,588  

Change in fair value of debt

     41,634       333,879       (1,235,032     950,238       90,719  

Unrealized (gain) loss on policies

     —         (3,305,505     3,305,505       —         —    

Unrealized (gain) on investments

     15,953       1,039,022       246,846       (256,199     1,045,623  

Total operating expenses

     3,073,082       1,304,590       4,680,334       4,431,751       13,489,758  

Operating Income

     7,491,412       5,242,671       10,545,428       10,341,610       33,621,122  

Other (expense) / income

          

Other (expense)

     (114,792     (127,181     42,288       (147,054     (346,740

Interest (expense)

     0       —         (2,954     (48,661     (51,615

Interest income

     548       599       358       2,167       3,672  

Total other (expense) / income

     (114,244     (126,582     39,691       (193,547     (394,682


Net income before tax

     7,377,169       5,116,089       10,585,120       10,148,063       33,226,440  

Income tax (benefit)

     1,325       296,806       242,544       351,286       891,961  

Net income

     7,375,844       4,819,283       10,342,576       9,796,777       32,334,479  

Less: Net income (loss) attributable to non-controlling interests

     —         406,641       405,967       (27,844     784,764  

Net income attributable to Longevity Market Assets, LLC

     7,375,844       4,502,884       9,936,609       9,824,621       31,549,715  

Net income

     7,375,844       4,819,283       10,342,576       9,796,777       32,334,479  

Depreciation and amortization expense

     3,983       4,146       6,373       4,087       18,588  

Income tax

     1,325       296,806       242,544       351,286       891,961  

Other (expense)

     114,792       127,181       (42,288     147,054       346,740  

Interest expense

     (0     —         2,954       48,661       51,615  

Interest income

     (548     (599     (358     (2,167     (3,672

Loss on change in fair value of debt

     41,634       333,879       (1,235,032     950,238       90,719  

Unrealized (gain) on investments

     15,953       1,039,022       246,846       (256,199     1,045,623  

Adjusted EBITDA

     7,552,983       6,619,719       9,563,615       11,039,736       34,776,053  


LONGEVITY MARKET ASSETS, LLC

STATEMENT OF OPERATIONS AND COMPREHENSIVE INCOME

FY 2022

 

     Three months
ended
March 31,
     Three months
ended
June 30,
    Three months
ended
September 30,
     Three months
ended
December 31,
     Full Year  
     2022 Q1      2022 Q2     2022 Q3      2022 Q4      2022  

Revenues

             

Portfolio servicing revenue

             

Related-party service revenue

     200,905        419,253       132,220        65,921        818,299  

Portfolio Servicing revenue

     370,000        169       250,025        32,479        652,673  

Total portfolio servicing revenue

     570,905        419,422       382,245        98,400        1,470,972  

Active management revenue

             

Investment Income from life insurance policies held using investment method

     8,015,000        5,965,466       10,629,978        13,218,386        37,828,829  

Change in fair value of life insurance policies (policies held using fair value method)

     1,291,492        (1,291,492     3,801,031        1,612,721        5,413,751  


Total active management revenue

     9,306,492       4,673,974       14,431,008       14,831,106       43,242,581  

Total revenues

     9,877,397       5,093,396       14,813,253       14,929,506       44,713,553  

Cost of revenues (excluding depreciation stated below)

     1,419,956       666,119       1,754,894       2,404,163       6,245,131  

Gross profit

     8,457,441       4,427,277       13,058,360       12,525,344       38,468,422  

Operating expenses:

          

Sales and marketing

     630,000       1,019,498       14,905       931,737       2,596,140  

General, administrative and other

     641,205       5,499       59,816       359,883       1,066,403  

Other operating expense

     —         —         (2,141     —         (2,141

Depreciation

     1,043       1,098       3,212       1,071       6,423  

Change in fair value of debt

     41,634       333,879       (1,235,032     950,238       90,719  

Unrealized (gain) loss on policies

     —         (3,305,505     3,305,505       —         —    

Unrealized (gain) on investments

     15,953       1,039,022       246,846       (256,199     1,045,623  

Total operating expenses

     1,329,835       (906,509     2,393,111       1,986,729       4,803,168  

Operating Income

     7,127,605       5,333,786       10,665,248       10,538,614       33,665,254  

Other (expense) / income

          

Other (expense)

     (114,792     (127,455     42,288       (147,054     (347,013


Interest (expense)

     —         —         —         (42,798     (42,798

Interest income

     —         —         —         1,474       1,474  

Total other (expense) / income

     (114,792     (127,455     42,288       (188,378     (388,337

Net income before tax

     7,012,813       5,206,331       10,707,536       10,350,236       33,276,917  

Income tax (benefit)

     —         296,806       241,962       351,176       889,943  

Net income

     7,012,813       4,909,525       10,465,574       9,999,061       32,386,974  

Less: Net income (loss) attributable to non-controlling interests

     —         406,641       405,967       (27,844     784,764  

Net income attributable to Longevity Market Assets, LLC

     7,012,813       4,502,884       10,059,607       10,026,905       31,602,210  

Net income

     7,012,813       4,909,525       10,465,574       9,999,061       32,386,973  

Depreciation and amortization expense

     1,043       1,098       3,212       1,071       6,423  

Income tax

     —         296,806       241,962       351,176       889,943  

Other (expense)

     114,792       127,455       (42,288     147,054       347,013  

Interest expense

     —         —         —         42,798       42,798  

Interest income

     —         —         —         (1,474     (1,474

Loss on change in fair value of debt

     41,634       333,879       (1,235,032     950,238       90,719  

Unrealized (gain) on investments

     15,953       1,039,022       246,846       (256,199     1,045,623  

Adjusted EBITDA

     7,186,236       6,707,785       9,680,275       11,233,724       34,808,019  


ABACUS SETTLEMENTS, LLC

STATEMENT OF OPERATIONS

FY 2022

 

     Three months
ended
March 31,
     Three months
ended
June 30,
     Three months
ended
September 30,
     Three months
ended
December 31,
     Full Year  
     2022 Q1      2022 Q2      2022 Q3      2022 Q4      2022  

Revenue

     2,441,680        743,388        1,766,853        2,098,086        7,050,007  

Related party revenue

     4,881,067        4,948,528        4,264,628        4,059,233        18,153,456  

Total revenue

     7,322,747        5,691,916        6,031,481        6,157,319        25,203,463  

Cost of sales

              

Cost of sales (exclusive of items shown separately below)

     2,308,688        956,625        933,089        1,340,069        5,538,470  

Related party cost of sales

     2,907,005        2,615,307        2,930,990        2,569,233        11,022,535  

Total cost of sales

     5,215,693        3,571,932        3,864,079        3,909,302        16,561,005  

Gross profit

     2,107,054        2,119,984        2,167,402        2,248,018        8,642,458  

Operating expenses:

              

General and administrative expenses

     1,740,307        2,208,051        2,284,061        2,442,006        8,674,425  


Depreciation and amortization expense

     2,940        3,048       3,161       3,016       12,165  

Total operating expenses

     1,743,247        2,211,099       2,287,222       2,445,022       8,686,590  

Income (loss) from operations

     363,807        (91,115     (119,820     (197,004     (44,132

Other income (expense)

           

Interest income

     548        599       358       694       2,199  

Interest expense

     0        —         (2,954     (5,863     (8,817

Other income (expense)

     —          273       —         —         273  

Total other income (expense)

     548        872       (2,596     (5,169     (6,345

Income before income taxes

     364,356        (90,242     (122,417     (202,173     (50,477


Provision for income taxes

     1,325       —         582       111       2,018  

Net income and comprehensive income (loss)

   $ 363,031     $ (90,242   $ (122,999   $ (202,284   $ (52,494

Net income and comprehensive income (loss)

   $ 363,031     $ (90,242   $ (122,999   $ (202,284     (52,494

Depreciation and amortization expense

     2,940       3,048       3,161       3,016       12,165  

Provision for income taxes

     1,325       —         582       111       2,018  

Interest income

     (548     (599     (358     (694     (2,199

Interest expense

     0       —         (2,954     (5,863     (8,817

Adjusted EBITDA

   $ 366,747     $ (87,793   $ (122,567   $ (205,714   $ (49,327